Breast cancer (BC) is a heterogeneous disease that is classified into different subtypes depending on the expression of the estrogen and progesterone receptors and the amplification of human epidermal growth factor receptor 2 (HER2/ERBB2) (1). This evidence concerns the gene PGR and breast carcinoma.